Related Experiment Video
Updated: May 23, 2025

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Sleep Quality and Quantity in Caregivers of Children with Type 1 Diabetes Using Closed-Loop Insulin Delivery or a
Juan J Madrid-Valero1, Julia Ware2,3, Janet M Allen2
1Department of Health Psychology, Faculty of Health Sciences, University of Alicante, San Vicente del Raspeig, Spain.
Insights
Parents using closed-loop (CL) systems for children with type 1 diabetes (T1D) reported better sleep quality, fewer awakenings, and less time awake after sleep onset compared to sensor-augmented pump (SAP) therapy. While not statistically significant, findings suggest CL may improve caregiver sleep.
Area of Science:
- Pediatric Endocrinology
- Sleep Medicine
- Diabetes Technology
Background:
- Parental sleep disturbances are common in children with type 1 diabetes (T1D).
- Advanced diabetes management technologies, such as closed-loop (CL) systems, aim to improve patient outcomes and potentially alleviate caregiver burden.
- Understanding the impact of different diabetes management systems on parental sleep is crucial for holistic care.
Purpose of the Study:
- To compare sleep quality and quantity in parents of children with T1D using either a CL system or sensor-augmented pump (SAP) therapy.
- To investigate potential differences in sleep duration, efficiency, and awakenings between the two technology groups.
Main Methods:
- Sleep data were collected from 40 parents of children (aged 1-7 years) with T1D using sleep diaries, accelerometers (Actiwatch), and the Pittsburgh Sleep Quality Index.
- Parents were categorized as caregiver 1 (main analysis) or caregiver 2 (supplementary analysis).
- Data were assessed at a single post-randomization time point during the child's participation in either the CL or SAP arm of a clinical study.
Main Results:
- While group differences were not statistically significant (p < 0.05), caregiver 1 data indicated trends favoring the CL group.
- Parents in the CL group reported shorter sleep duration but better sleep quality, fewer awakenings, and less wake after sleep onset (WASO) via sleep diaries.
- Actiwatch data showed shorter sleep latency, greater sleep efficiency, and less WASO for caregiver 1 in the CL group compared to the SAP group.
Conclusions:
- Sleep quality and quantity in parents using CL systems were not significantly different from those using SAP systems.
- However, effect sizes and the direction of non-significant results suggest that CL treatment may be associated with improved sleep quality for primary caregivers.
- Further research is warranted to confirm these potential benefits of CL systems on parental sleep in T1D management.
Introduction:
Parents of children living with type 1 diabetes (T1D) often report short and/or poor quality sleep. The development of closed-loop systems promises to transform the management of T1D. This study compared sleep quality and quantity in caregivers of children using a closed-loop system (CL) or sensor-augmented pump (SAP) therapy.
Method:
Data from sleep diaries, accelerometers, and questionnaires were provided by forty parents (classified as caregiver 1 (main analyses) or 2 (supplementary analyses) based on their contribution towards treatment management) of 21 very young children aged 1 to 7 years living with T1D (mean age: 4.7 (SD = 1.7)). Assessments were made at a single post-randomisation time point when the child was completing either the 16-week CL arm (n = 10) or the 16-week SAP arm (n = 11) of the main study.
Results:
Overall, there was a mixed pattern of results and group differences were not statistically significant at the p < 0.05 level. However, when we consider the direction of results and results from caregiver 1, sleep diary data showed that parents of the CL (as compared to the SAP) group reported a shorter sleep duration but better sleep quality, fewer awakenings, and less wake after sleep onset (WASO). Actiwatch data showed that caregiver 1 of the CL (as compared to the SAP) group had a shorter sleep latency; greater sleep efficiency; and less wake after sleep onset. Results from the Pittsburgh Sleep Quality Index also showed better sleep quality for caregiver 1 of the CL group as compared to the SAP group.
Conclusions:
Results from this study suggest that sleep quality and quantity in parents of children using CL were not significantly different to those using SAP. Considering effect sizes and the direction of the non-significant results, CL treatment could be associated with better sleep quality in the primary caregiver. However, further research is needed to confirm these findings. This trial is registered with NCT05158816.
Related Concept Videos
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Insulin Formulations: Types and Delivery
Short-acting insulins are divided into...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Pulse rhythm
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
Special considerations while measuring oxygen saturation
Ensuring accuracy in vital sign recordings while prioritizing patient comfort and minimizing anxiety is...
Diabetes Mellitus: Type 2 and Gestational

